Un tunnel “da riaprire” dopo tanti anni di dialisi

Coppo R. Non-steroidal and non cytotoxic therapies for nephritic syndrome. Nephrol Dial Transplant 2008; 23(6): 1793–96.

Berg A.L. , Nilsson-Ehle P. , Arnadottir M. Benefical effects of ACTH on serum lipoprotein profile and glomerular function in patients with membranous nephropathy. Kidney Int 1999; 56: 1534–43.

Berg A.L. , and Arnadottir M. ACTH-induced improvement in nephritic syndrome in patients with a variety of diagnoses. Nephrol Dial Transplant 2004; 19: 1305–07.

Rauen T. , Michealis A. , Fleoge J. , Mertens P.R. Case series of idiopathic membranous nephropathy with long-term beneficial effects of ACTH peptide 1–24. Clin Nephrol 2009; 71(6): 637–42.

Ponticelli C. , Passerini P. , Salvadori M. . A Randomized Pilot Trial Comparing Methylprednisolone Plus a Cytotoxic Agent Versus Synthetic Adrenocorticotropic Hormone in Idiopatic Membranous Nephropathy. Am J Kid Dis 2006; 47(2): 233–40.

Joles J.A. , Kunter U. , Janssen U. . Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats. J Am Soc Nephrol 2000; 11(4): 669–83.

Attia D.M. , Ni Z.N. , Boer P. . Proteinuria is preceded by decreased nitric oxide synthesis and prevented by a NO donor in cholesterol-fed rats. Kidney Int 2002; 61: 1776–87.

Attia D.M. , Feron O. , Goldschmeding R. . Hypercholesterolemia in rats induces podocytes stress and decreases renal cortical nitric oxide synthesis via an angiotensin II type receptor-sensitive mechanism. J Am Soc Nephrol 2004; 15(4): 949–57.

Keane W.F. Effect of lipids on glomerular injury and progression of renal disease. Verh K Acad Geneeskd Belg 1994; 56(2): 91–104.

Lorusso P. , Cipollini I. , Bottai A. , Barsotti G. Effetto dell'ACTH sulla proteinuria nelle glomerulonefriti. Giornale Italiano di Nefrologia 2009; 26: S47, Settembre-Ottobre 2009, S32, Abstract.

Abeyagunawardena A.S. , Hindmarsh P. , Trompeter R.S. Adenocortical suppression increases the risk of relapse in nephritic syndrome. Arc Dis Child 2007; 92(7): 585–8.